Results 41 to 50 of about 1,960 (158)

Pachychoroid disease

, 2019
Pachychoroid disease, as originally described, includes a multitude of clinical presentations along a spectrum that includes central serous chorioretinopathy.
Dansingani, Kunal K., Serena Fragiotta, Fragiotta, Serena, Freund, K. Bailey, Kunal K. Dansingani, K. Bailey Freund   +5 more
core   +1 more source

Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy

Ophthalmology Science
Purpose: To elucidate the clinical characteristics and progression rates of pachychoroid and conventional geographic atrophy (GA). Design: Retrospective, multicenter, observational study.
Yukiko Sato, MD, Naoko Ueda-Arakawa, MD, PhD, Ayako Takahashi, MD, PhD, Masahiro Miyake, MD, PhD, Yuki Mori, MD, PhD, Yasunori Miyara, MD, Chikako Hara, MD, PhD, Yoko Kitajima, MD, Ruka Maruko, MD, PhD, Moeko Kawai, MD, Hajime Takahashi, MD, PhD, Hideki Koizumi, MD, PhD, Maiko Maruyama-Inoue, MD, PhD, Yasuo Yanagi, MD, PhD, Tomohiro Iida, MD, PhD, Kanji Takahashi, MD, PhD, Taiji Sakamoto, MD, PhD, Akitaka Tsujikawa, MD, PhD   +17 more
doaj   +1 more source

Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy

Medicina, 2021
Background and Objectives: Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC).
Michał Chrząszcz, Weronika Pociej-Marciak, Katarzyna Żuber-Łaskawiec, Bożena Romanowska-Dixon, Marek Sanak, Katarzyna Michalska-Małecka, Mojca Globočnik Petrovič, Izabella Karska-Basta   +7 more
doaj   +1 more source

Risk factors for the development of subretinal fluid in the fellow eyes of patients with chronic central serous chorioretinopathy

Acta Ophthalmologica, Volume 104, Issue 6, Page 666-673, September 2026.
Abstract Purpose To assess the risk of subretinal fluid (SRF) development in the fellow eye of chronic central serous chorioretinopathy (cCSC) patients with unilateral SRF at baseline. Methods Medical records of 334 presumed cCSC patients were retrospectively reviewed.
Helena M. A. Feenstra, Tahir Cakar, Joost Brinks, Camiel J. F. Boon, Elon H. C. van Dijk   +4 more
wiley   +1 more source

Updated review of the pachychoroid spectrum and central serous chorioretinopathy [PDF]

Revista Brasileira de Oftalmologia
The pachychoroid disease spectrum (PDS) encompasses a range of chorioretinal disorders characterized by increased choroidal thickness, dilated Haller's layer vessels (pachyvessels), and choroidal hyperpermeability, often associated with retinal pigment ...
Heitor Santos Nogueira, Mateus Pimenta Arruda, João Pedro Romero Braga, José Augusto Cardillo, Luiz H. Lima   +4 more
doaj   +1 more source

Neovascular glaucoma in atypical central serous chorioretinopathy and pachychoroid disease

Indian Journal of Ophthalmology. Case Reports, 2022
We report an atypical central serous chorioretinopathy (CSCR) with pachychoroid disease and consequent recalcitrant neovascular glaucoma (NVG). A 45-year-old man with persistent subretinal fluid, pachychoroid and bilateral large areas of capillary ...
Aparna Rao, Srikanta Kumar Padhy
doaj   +1 more source

An eye on long‐duration spaceflight: Controversies, countermeasures and challenges

Experimental Physiology, Volume 111, Issue 9, Page 4004-4014, 1 September 2026.
Abstract Space flight‐associated neuroocular syndrome (SANS) is a consequence of long‐duration space flight and is detected in two‐thirds of astronauts. In‐flight, this can cause a change in the refraction of the eyes, requiring graded hypermetropic ‘superfocus adjustable’ glasses, optic nerve head oedema and choroidal folds.
Vincent Wing Sum Ng, Susan Patricia Mollan   +1 more
wiley   +1 more source

EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY

, 2016
PURPOSE: To correlate clinical manifestations with choroidal morphology in pachychoroid disorders, including central serous chorioretinopathy, pachychoroid pigment epitheliopathy, pachychoroid neovasculopathy, and polypoidal choroidal vasculopathy, using
Naysan, J., Balaratnasingam, C., Freund, K. B., Dansingani, K. K.   +3 more
core   +1 more source

Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4

Acta Ophthalmologica, Volume 104, Issue 5, Page e565-e577, August 2026.
Abstract Purpose Assessing the 24‐month treatment outcome of half‐dose photodynamic therapy (PDT) or oral eplerenone in chronic central serous chorioretinopathy (cCSC). Methods Multicentre randomized clinical trial included cCSC patients from the SPECTRA trial who were randomized to receive half‐dose PDT or oral eplerenone.
Helena M. A. Feenstra, Issam El Mansori, Thomas J. van Rijssen, Roula Tsonaka, Roselie M. H. Diederen, Carel B. Hoyng, Reinier O. Schlingemann, Camiel J. F. Boon, Elon H. C. van Dijk   +8 more
wiley   +1 more source

The prechoroidal cleft in neovascular age‐related macular degeneration

Acta Ophthalmologica, Volume 104, Issue 4, Page 364-375, June 2026.
Abstract The prechoroidal cleft is a lenticular, hypo‐reflective space on optical coherence tomography imaging, located between a band of fibrovascular material underneath the retinal pigment epithelium (RPE) and Bruch's membrane. It occurs in 8%–22% of neovascular age‐related macular degeneration (nAMD) eyes, most often with macular neovascularization
Niels J. Brouwer, T. H. Khanh Vu, Yvonne De Jong‐Hesse, Elon H. C. van Dijk   +3 more
wiley   +1 more source